On ECHEMI
Home > Drugs > Anhui Huarun Jinchan Pharmaceutical Co., Ltd.
Anhui Huarun Jinchan Pharmaceutical Co., Ltd.
  • Founded in:

    2000-07-18
  • Country:

    China China
  • Address:

    No. 39, Longfa Road, Huaibei City, Anhui Province
  • Tax NO.:

    913406007199864132
  • Registered Funds:

    165.9 million yuan
  • Website:

  • Email:

Related Drugs
Cinobufacini Injection
This product is an extract from dried toad skin.
Name Description Content CAS NO. Registered Holders
Dried Toad Skin Extract

1. Anti-tumor effect: It has a significant tumor-suppressing effect on a variety of mouse transplanted tumors, can directly kill tumor cell DNA, and cause tumor cell necrosis; it has a synergistic effect when used in combination with chemotherapy drugs such as CTX, which can improve the efficacy and reduce the toxic side effects of radiotherapy and chemotherapy. 2. Immunopromoting effect: It has a preventive and therapeutic effect on leukopenia caused by CTX, can increase the lymphocyte ratio and the content of IgG, IgA, and IgM in serum, and enhance humoral immunity and cellular immunity. 3. Antiviral effect: It has a significant inhibitory effect on the replication of 2215 cells and duck hepatitis B virus.

More

1. Anti-tumor effect: It has a significant tumor-suppressing effect on a variety of mouse transplanted tumors, can directly kill tumor cell DNA, and cause tumor cell necrosis; it has a synergistic effect when used in combination with chemotherapy drugs such as CTX, which can improve the efficacy and reduce the toxic side effects of radiotherapy and chemotherapy. 2. Immunopromoting effect: It has a preventive and therapeutic effect on leukopenia caused by CTX, can increase the lymphocyte ratio and the content of IgG, IgA, and IgM in serum, and enhance humoral immunity and cellular immunity. 3. Antiviral effect: It has a significant inhibitory effect on the replication of 2215 cells and duck hepatitis B virus.

0
Gallbladder Benefit Tablets
Curcuma, honeysuckle, alum, licorice, saltpeter, talc, and Scrophularia.
Name Description Content CAS NO. Registered Holders
CURCUMAE RADIX

0
LONICERAE JAPONICAE FLOS

0
Aluminium potassium sulfate dodecahydrate

7784-24-9 3
DGL

0
Potassium nitrate

0
Talc

14807-96-6 26
Scrophulariae Radix

0
Kunyuan Tongru Oral Liquid
Ginseng, fenugreek, white peony root, loofah, angelica, sea cucumber, astragalus, and smilax glabra.
Name Description Content CAS NO. Registered Holders
ASIAN GINSENG

0
Vaccariae Semen

0
PAEONIAE RADIX ALBA

0
LUFFAE FRUCTUS RETINERVUS

0
Angelicae Sinensis Radix

0
Sea Cucumber Powder

0
Astragali Radix

0
Swisscentaury Root Extract

0
Ibuprofen tablets
Ibuprofen
Name Description Content CAS NO. Registered Holders
Ibuprofen

This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.

More

This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.

15687-27-1 53
Ribavirin Injection
The main ingredient of this product is ribavirin, whose chemical name is 1-beta;-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide.
Name Description Content CAS NO. Registered Holders
Ribavirin

A broad-spectrum antiviral drug that inhibits the growth of multiple viruses in vitro, including respiratory syncytial virus, influenza virus, hepatitis A virus, and adenovirus. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase, and mRNA guanosine transferase, thereby causing a reduction in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus.

More

A broad-spectrum antiviral drug that inhibits the growth of multiple viruses in vitro, including respiratory syncytial virus, influenza virus, hepatitis A virus, and adenovirus. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase, and mRNA guanosine transferase, thereby causing a reduction in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus.

36791-04-5 33
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.